logo-loader
viewAmryt Pharma PLC

Amryt Pharma's Joe Wiley delighted as company begins trading on NASDAQ

Amryt Pharma PLC's (LON:AMYT) Joe Wiley speaks to Proactive London's Andrew Scott as the company began trading on NASDAQ.

Wiley says he's delighted and it's a big day for the company which they've been building towards for some time.

He's hoping the move will 'enhance the value of its equity on both sides of the Atlantic' as well as broaden its analyst coverage.

Quick facts: Amryt Pharma PLC

Price: 206 GBX

AIM:AMYT
Market: AIM
Market Cap: £335.37 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Amryt Pharma PLC named herein, including the promotion by the Company of Amryt Pharma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Market report: Sterling six week lows and further lockdown woes

The FTSE is higher as we head into early afternoon trade with Sterling still loitering around that six week low and news from drug giant AstraZeneca PLC (LON:AZN) that it is putting its coronavirus vaccine trials on hold after a patient participating got poorly which has triggered...

on 9/9/20

2 min read